Real-world treatment of large B-cell lymphoma with chimeric antigen receptor T-cell therapy after loncastuximab tesirine

EJHaem. 2024 Sep 2;5(5):1110-1113. doi: 10.1002/jha2.993. eCollection 2024 Oct.

Authors

Mehdi Hamadani¹, Melanie Lucero², Jakob D DeVos³, Lei Chen²

Affiliations

¹ Division of Hematology and Oncology & Center for International Blood and Marrow Transplant Research Medical College of Wisconsin Milwaukee Wisconsin USA.
² Health Economics and Outcomes Research ADC Therapeutics New Providence New Jersey USA.
³ Center for International Blood and Marrow Transplant Research Medical College of Wisconsin Milwaukee Wisconsin USA.

No abstract available

© 2024 The Author(s). eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.

Publication types

Editorial

Grants and funding

U24 CA076518/CA/NCI NIH HHS/United States